Related Experiment Videos
[Clinical effectiveness of Duracef in children with ENT inflammation]
Insights
Duracef effectively treats acute ear, nose, and throat inflammation in children. While beneficial for acute conditions, it showed limited effectiveness in chronic inflammatory disease exacerbations.
Area of Science:
- Pediatric Otolaryngology
- Infectious Diseases
Background:
- Bacterial infections of the ear, nose, and throat (ENT) are common in children.
- Antibiotic therapy is a cornerstone in managing pediatric ENT inflammation.
- Duracef (cefadroxil) is a cephalosporin antibiotic with activity against common respiratory pathogens.
Purpose of the Study:
- To evaluate the efficacy and tolerability of Duracef in treating acute and chronic (exacerbation) ENT inflammation in pediatric patients.
- To assess Duracef's effectiveness across different sites of pediatric ENT infection.
Main Methods:
- A study involving 106 children aged 4 to 14 years.
- Children received Duracef for various acute and chronic (exacerbation) ENT inflammatory conditions.
- Treatment outcomes were assessed based on clinical improvement and tolerability.
Main Results:
- Duracef demonstrated high effectiveness in treating acute pharyngeal, paranasal sinus, and ear inflammations.
- The drug was found to be beneficial in acute settings due to its efficacy, low toxicity, and convenient administration.
- Duracef showed insufficient effectiveness in managing exacerbations of chronic inflammatory ENT diseases.
Conclusions:
- Duracef is a beneficial antibiotic for acute pediatric ENT infections.
- Its favorable tolerability profile and cost-effectiveness make it a suitable option for acute conditions.
- Further investigation may be warranted for optimizing treatment of chronic inflammatory ENT disease exacerbations in children.
Abstract:
106 children aged 4 to 14 years received duracef for different acute and chronic (exacerbation) ENT inflammation. The drug proved highly effective in acute diseases of the parynx, paranasal sinuses and ear. In exacerbations of chronic inflammatory diseases it was insufficiently effective. In acute inflammation use of duracef is beneficial as it is effective, inexpensive, low toxic, convenient in administration, is well tolerated, friendly to the intestine.